Molecular biology of human papillomavirus infection and cervical cancer
The DOI matches its Crossref record; 172 of the 179 references it cites were found in a registry or an index.
Abstract
HPVs (human papillomaviruses) infect epithelial cells and cause a variety of lesions ranging from common warts/verrucas to cervical neoplasia and cancer. Over 100 different HPV types have been identified so far, with a subset of these being classified as high risk. High-risk HPV DNA is found in almost all cervical cancers (>99.7%), with HPV16 being the most prevalent type in both low-grade disease and cervical neoplasia. Productive infection by high-risk HPV types is manifest as cervical flat warts or condyloma that shed infectious virions from their surface. Viral genomes are maintained as episomes in the basal layer, with viral gene expression being tightly controlled as the infected cells move towards the epithelial surface. The pattern of viral gene expression in low-grade cervical lesions resembles that seen in productive warts caused by other HPV types. High-grade neoplasia represents an abortive infection in which viral gene expression becomes deregulated, and the normal life cycle of the virus cannot be completed. Most cervical cancers arise within the cervical transformation zone at the squamous/columnar junction, and it has been suggested that this is a site where productive infection may be inefficiently supported. The high-risk E6 and E7 proteins drive cell proliferation through their association with PDZ domain proteins and Rb (retinoblastoma), and contribute to neoplastic progression, whereas E6-mediated p53 degradation prevents the normal repair of chance mutations in the cellular genome. Cancers usually arise in individuals who fail to resolve their infection and who retain oncogene expression for years or decades. In most individuals, immune regression eventually leads to clearance of the virus, or to its maintenance in a latent or asymptomatic state in the basal cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“human papillomavirus (HPV) is thought to initiate cervical carcinoma and squamous cell carcinoma of the head and neck in part by inactivating RB through expression of the E7 oncoprotein21,22”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
In the citing paper
“in HPV-induced cervical cancers, the virus initiates cancer in dividing cells in the basal layer of the epithelium, preventing their normal cell cycle exit and maturation21.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [21]
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Classification of papillomaviruses
de Villiers, E.-M., Fauquet, C., Broker, T. R., Bernard, H.-U., & zur Hausen, H. (2004) · Virology · doi:10.1016/j.virol.2004.03.033 · Cited by 3,193
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
Clifford, G. M., Smith, J. S., Plummer, M., Muñoz, N., & Franceschi, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600688 · Cited by 1,561
Barrier Function of the Skin: “La Raison d'Être” of the Epidermis
Madison, K. C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12359.x · Cited by 1,188
Muñoz, N., Bosch, F. X., Castellsagué, X., Díaz, M., de Sanjose, S., Hammouda, D., Shah, K. V., & Meijer, C. J. L. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20244 · Cited by 1,104
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Münger, K., Phelps, W. C., Bubb, V, Howley, P. M., & Schlegel, R. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4417-4421.1989 · Cited by 1,030
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., DeRouen, T. A., Galloway, D. A., Vernon, D., & Kiviat, N. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199210293271804 · Cited by 943
Research works printed but not linked: 2
- Villiers de, 2001, Taxonomic classification of papillomaviruses, Papillomavirus Rep., 12, 57
- Sorathia, 2004, The E4 protein of HPV16 Interacts with E2 and regulates the trans-activation and replication functions of E2, 318
Cited by
Items 601–700 of 1,000
Castle, P. E., Wentzensen, N., Wheeler, C. M., Rydzak, G., & SCHIFFMAN, M. H. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181bb5632 · Cited by 7
Chakraborty, S., Li, X.-Z., & Roy, P. K. (2019) · International Journal of Biomathematics · doi:10.1142/s1793524519500700 · Cited by 7
Reyna‐Rodríguez, I. L., Chávez‐Álvarez, S., Garza‐Rodríguez, V., Franco‐Márquez, R., González‐Martínez, G., Ocampo‐Candiani, J., & Villarreal‐Martínez, A. (2021) · Archives of Dermatological Research · doi:10.1007/s00403-020-02182-y · Cited by 8
Bénéteau, T., Selinger, C., Sofonea, M. T., & Alizon, S. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009352 · Cited by 7
“In basal (stem) cells, the number of viral copies is usually considered to be limited to several dozens of episomes per cell: 10 to 200 according to Doorbar [16], and 50 to 100 according to more recent work [12].”
BackgroundThe interaction between human papilloma viruses related cancers and non-coding RNAs
Ghafouri‐Fard, S., Hussen, B. M., Shaterabadi, D., Abak, A., Shoorei, H., Taheri, M. N., & Rakhshan, A. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153939 · Cited by 8
Modeling HPV-Associated Disease and Cancer Using the Cottontail Rabbit Papillomavirus
Cladel, N. M., Xu, J., Peng, X., Jiang, P., Christensen, N. D., Zheng, Z., & Hu, J. (2022) · Viruses · doi:10.3390/v14091964 · Cited by 7
Trammel, J., Amusan, O. T., Hultgren, A., Raikhy, G., & Bodily, J. M. (2023) · Virology · doi:10.1016/j.virol.2023.109952 · Cited by 7
Dellino, M., Pinto, G., D’Amato, A., Barbara, F., Gennaro, F. D., Saracino, A., Laganà, A. S., Vimercati, A., Malvası, A., Malvasi, V. M., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13051429 · Cited by 8
Molecular Diagnosis of Human Papillomavirus Infections
Meln, S., Álvarez‐Argüelles, M. E., & de, M. (2013) · InTech eBooks · doi:10.5772/55706 · Cited by 8
Aspectos imunológicos da infecção pelo vírus do papiloma humano (HPV)
Limberger, A., de Oliveira, C. F., Corrêa, M. P., Reus, T. L., Oda, J. M. M., Ketelut-Carneiro, N., & Watanabe, M. A. E. (2012) · Semina Ciências Biológicas e da Saúde · doi:10.5433/1679-0367.2012v33n1p111 · Cited by 7
Martorell, M., García, J. Á., Ortiz‐Villalón, C., Pérez‐Vallés, A., Calabuig, C., Gómez-Cabrero, D., Escolano, M., & Montesinos, M. (2010) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365541003602056 · Cited by 7
Demos, L. E., Munday, J. S., Lange, C. E., & Bennett, M. D. (2018) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x18795919 · Cited by 7
Kneller, J. M., Ehlen, T. G., Matisic, J., Miller, D. M., van Niekerk, D., Lam, W. L., Marra, M. A., Richards-Kortum, R. R., Follen, M., MacAulay, C. E., et al. (2007) · Biomarker Insights · doi:10.1177/117727190700200020 · Cited by 7
de Oliveira, G. R., de Carvalho, P. S., Vieira, V. C., Curty, G., Basto, D. L., Moreira, M. Â. M., & Soares, M. A. (2022) · Viruses · doi:10.3390/v14122653 · Cited by 8
Guerra, F., Rocher, A. E., Hidalgo, J. V., Díaz, L., Vighi, S., Cardinal, L., Tatti, S., Cuneo, N. A., Gay, G. D. P., Camporeale, G., et al. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12380 · Cited by 7
“It has been established that the persistence of the infection with some of the oncogenic genotypes or high-risk HPV is a necessary but not sufficient condition for the development of cervical cancer.(5,6) When there is an infection by high-risk HPV genotypes, the expression of the viral oncoproteins, such as E6 and E7…”
BackgroundZsemlye, M. M. (2013) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2013.03.008 · Cited by 7
Vilchez, J. R., Torres‐Moreno, D., Martínez-Senac, M. M., Trujillo‐Santos, J., & Conesa‐Zamora, P. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.07.006 · Cited by 7
Molecular analysis of oncogenicity of the transcription factor, BRN3A, in cervical cancer cells
Purkayastha, B. P. D., & Roy, J. K. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1059-0 · Cited by 7
Expression of HLA-I, CD8, and CD4 and Their Clinical Significance in Cervical Cancer
Fan (2011) · World Journal of Oncology · doi:10.4021/wjon286w · Cited by 7
“Doobar’s research [4] also indicates the host’s immune system may play an important role in cervical cancer occurrence and progression.”
BackgroundComparative analysis of three methods for HPV DNA detection in cervical samples.
Michelli, E., Téllez, L., Mendoza, J. A., Jürgensen, C., Muñoz, M., Pérez, S., Mosqueda, N., Hernández, E., Noguera, M. E., Diana Callejas, M., et al. (2011) · PubMed · Cited by 8
PAPILOMAVÍRUS HUMANO: PREVENÇÃO E DIAGNÓSTICO
Rodrigues, A. F., & Sousa, J. A. (2016) · Revista de Epidemiologia e Controle de Infecção · doi:10.17058/reci.v5i4.6043 · Cited by 7
Host Immune Responses Associated with Clearance or Persistence of Human Papillomavirus Infections
Passmore, J.-A. S., & Williamson, A. (2016) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-016-0163-1 · Cited by 7
Effects of HPV Pseudotype Virus in Cutting E6 Gene Selectively in SiHa Cells
Cheng, Y., Chen, G., Yang, X. P., Wang, Y., & Li, H. (2018) · Current Medical Science · doi:10.1007/s11596-018-1868-3 · Cited by 7
Tang, Y. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397169-2.00023-8 · Cited by 7
Huo, W., Zhai, S., Wang, Y., Qiang, X., Na, R., Gui, H., Wu, N., Cao, Y., & Bai, H. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23207 · Cited by 7
Halpin, J. C., Whitney, D., Rigoldi, F., Sivaraman, V., Singer, A., & Keating, A. E. (2022) · Protein Science · doi:10.1002/pro.4429 · Cited by 7
“A PSSM based on the random library hits was used to identify candidate viral binders with better scores than human binders, and several viral peptides were found to bind with lowmicromolar affinities to the PDZ domain of SCRIB, a protein that is targeted by human papillomavirus [55,56].”
Wei, T., Li, Y., Zhang, Z., Xu, Y., Huang, H., Huang, Y., Li, J., Gong, Z., Hu, Z., Wang, Y. L., et al. (2026) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2026.111742 · Cited by 6
Banaszkiewicz, M., Constantinou, M., Pietrusiński, M., Kępczyński, Ł., Jędrzejczyk, A., Różniecki, M., Marks, P., & Kałużewski, B. (2013) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2013.01.art7 · Cited by 6
Walhart, T. A. (2015) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2015.07.001 · Cited by 6
“High-grade lesions have a more extensive proliferative phase than normal cells and the productive stages of the viral life cycle are either not supported or supported only poorly (Burk, Chen, & Van Doorslaerb, 2009; Doorbar, 2006).”
BackgroundMethodInfluentialNagamma, T., Seng, V. L. B., Leng, C. C. P., Alias, N. A., & Karim, N. A. (2016) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v15i4.23970 · Cited by 6
Domínguez-Catzín, V., Reveles-Espinoza, A. M., Sánchez-Ramos, J., Cruz-Cadena, R. E., Lemus-Hernández, D., & Garrido, E. (2017) · Virology Journal · doi:10.1186/s12985-017-0736-2 · Cited by 6
“cycle by amplifying progeny DNA genomes in the spinous layer and carrying out viral encapsidation in the uppermost epithelial layer named the granular layer [4].”
BackgroundAhmed, A. S. (2020) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/2861 · Cited by 8
Canché, J., Canul, J., Suárez, R., Anda, R. D., & González, M. R. (2011) · Revista Española de Sanidad Penitenciaria · doi:10.4321/s1575-06202011000300003 · Cited by 10
Human papillomavirus positive oropharyngeal cancer: The general information
Selçuk, Ö. T. (2016) · Egyptian Journal of Ear Nose Throat and Allied Sciences · doi:10.1016/j.ejenta.2016.07.007 · Cited by 6
Bermúdez-Morales, V. H., Fierros-Zárate, G. D. S., García, C., Alcocer-González, J. M., Morales-Ortega, A., Peralta-Zaragoza, Ó., Torres-Poveda, K., Burguete-García, A. I., Hernández-Márquez, E., & Madrid‐Marina, V. (2016) · Journal of Cancer · doi:10.7150/jca.15536 · Cited by 6
Nguyen, T. T. L., Tarapore, E., & Atwood, S. X. (2019) · Wiley eBooks · doi:10.1002/9783527814633.ch5 · Cited by 7
An overview of cancer and the human microbiome
Mahapatra, S., Mohanty, S., Mishra, R., & Prasad, P. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.07.007 · Cited by 7
Li, X., Wei, X., Liu, X., Wang, N., Xu, F., Liu, X., Li, Y., Zhou, Y., Tang, H., Bian, M., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11538-2 · Cited by 6
“A phylogenetic tree construction based on the nucleotide sequence of the L1 gene classified the HPV types into five genera – alpha, beta, gamma, mu and nu [3, 4].”
MethodLiverani, C. A. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-3011-9 · Cited by 10
“Thus cancer ultimately represents an abortive infection in which viral gene expression becomes deregulated and the normal life cycle of the virus cannot be completed [26].”
BackgroundDixon, E. P., Grønn, P., King, L. M., Passineau, H., Doobay, H., Skomedal, H., Hariri, J., Hay, S. N., Brown, C. A., Fischer, T. J., et al. (2012) · Journal of Virological Methods · doi:10.1016/j.jviromet.2012.07.006 · Cited by 6
Barbieri, D., Nebiaj, A., Strammiello, R., Agosti, R., Sciascia, S., Gallinella, G., Landini, M. P., Caliceti, U., & Venturoli, S. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.04.014 · Cited by 8
Kurmyshkina, O. V., Kovchur, P. I., & Volkova, T. O. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.11.4477 · Cited by 6
“As epithelial cells differentiate further, Е6 and Е7 pro-proliferative activity is counterbalanced by the mechanisms for negative regulation of the cell cycle, both on the part of the host cell and on the part of the virus (Doorbar, 2006).”
BackgroundCurrent Status of Plants as Vaccine Production Platforms
Rogalska, T. (2012) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.s4-003 · Cited by 6
“There are over 130 genotypes of HPV; of these, 16 are considered high-risk types in the development of malignant tumors [39].”
BackgroundLi, J., Kovach, A. R., DeMonia, M., Slemmons, K. K., Oristian, K. M., Chen, C., & Linardic, C. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-95355-2 · Cited by 6
Recent developments in cancer vaccines
Mukherjee, B., Hoque, A. A., Chakraborty, A., Chakraborty, S., Dutta, L., Dutta, D., Banerjee, S., Dhara, M., & Deepa, R. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823686-4.00018-5 · Cited by 7
State-of-the-art of infections produced by human papillomavirus.
Reina, J. C., Muñóz, N., & Sánchez, G. I. (2008) · Colombia medica · doi:10.25100/cm.v39i2.576 · Cited by 6
Role of human papilloma virus (HPV) in common and genital warts and its relation to P53 expression.
Zekri, A. N., Bahnasy, A. A., Wm, S.-E., El-Din, H. M. A., Madbouly, M. S., Az, Z., El-Hoshy, K. H., El-Ramly, A., & Na, A.-H. (2006) · PubMed · Cited by 6
Multiple HPV subtypes infection in Japanese oral squamous cell carcinoma
Ono, K., Sugahara, K., Nomura, T., Takano, N., Shibahara, T., & Katakura, A. (2013) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2013.01.001 · Cited by 6
González‐Ruiz, I., Samayoa‐Descamps, V., Guagua-Cortez, K. A., González‐Moles, M. Á., & Ramos‐García, P. (2025) · Cancers · doi:10.3390/cancers17152427 · Cited by 6
“…exerts its tumor suppressor function by binding and inactivating E2F transcription factors, thereby blocking entry into the S phase and preventing uncontrolled cell cycle progression [60–66]—and a significantly elevated risk of malignant transformation in OL (RR = 2.00; 95% CI: 1.22–3.29) [42].”
InfluentialA synthetic system for RNA-responsive pyroptosis based on type III-E CRISPR nuclease-protease
He, M., Wang, W., Zhou, H., Liu, C., Zhao, C., Li, J. B., Han, Y., Qin, Y., & Chen, M. (2026) · Nature Communications · doi:10.1038/s41467-026-69179-5 · Cited by 5
“The integration of HPV DNA into the host genome results in the persistent expression of viral oncoproteins, particularly E6 and E7, making them pivotal targets for therapeutic vaccine development against HPV-associated malignancies 31 .”
Drozhdina, M. B. (2020) · Russian Journal of Clinical Dermatology and Venereology · doi:10.17116/klinderma202019061926 · Cited by 7
Effect of HPV Oncoprotein on Carbohydrate and Lipid Metabolism in Tumor Cells
Chen, B., Wang, Y., Wu, Y., & Xu, T. (2024) · Current Cancer Drug Targets · doi:10.2174/0115680096266981231215111109 · Cited by 5
The Role of HPV in the Development of Cutaneous Squamous Cell Carcinoma—Friend or Foe?
Dervenis, V. (2025) · Cancers · doi:10.3390/cancers17071195 · Cited by 5
Viruses with a Double-Stranded DNA Genome
Modrow, S., Falke, D., Truyen, U., & Schätzl, H. M. (2013) · Springer eBooks · doi:10.1007/978-3-642-20718-1_19 · Cited by 7
Reuschenbach, M. (2014) · HNO · doi:10.1007/s00106-014-2944-z · Cited by 5
Giant magnetoresistive biosensors for molecular diagnosis: surface chemistry and assay development
Yu, H., Osterfeld, S. J., Xu, L., White, R. L., Pourmand, N., & Wang, S. X. (2008) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.794434 · Cited by 5
“Infection with HPV is associated with various forms of cancers, including cervical cancer [10].”
BackgroundHurt, C. N., Nedjai, B., Alvarez-Mendoza, C., Powell, N. G., Tristram, A. J., & Jones, S. (2022) · Cancer Biomarkers · doi:10.3233/cbm-210448 · Cited by 5
MmuPV1 E6 induces cell proliferation and other hallmarks of cancer
Romero-Masters, J. C., Muehlbauer, L. K., Hayes, M., Grace, M. R., Shishkova, E., Coon, J. J., Münger, K., & Lambert, P. F. (2023) · mBio · doi:10.1128/mbio.02458-23 · Cited by 6
“…to as high-risk HPVs cause lesions in mucosal tissues that if allowed to persist can progress to anogenital and head and neck cancer (1–4 , The most well-studied HPV proteins are E5, E6, and E7 proteins which are critical for viral replication because they modulate the host cells to make…”
BackgroundMolecular Bases of Human Papillomavirus Pathogenesis in the Development of Cervical Cancer
Pedroza-Saavedra, A., Plett-Torres, T., Chihu-Amparán, L., Maldonado-Gama, M., Ana, M., Esquivel-Guadarrama, F. R., & Gutiérrez‐Xicoténcatl, L. (2012) · InTech eBooks · doi:10.5772/29020 · Cited by 6
“Other protein suggested to be expressed at the same time as E4 is E5, both of which may contribute to viral genome amplification (Doorbar, 2006; Syrjänen & Syrjänen, 1999).”
Syrjänen, S., Naud, P., Sarian, L. O., Derchain, S., Roteli-Martins, C. M., Longatto‐Filho, A., Tatti, S., Branca, M., Eržen, M., Hammes, L. S., et al. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181bccaec · Cited by 5
“In progression of cervical neoplasia, both spatial and quantitative deregulation of the tight transcriptional control is required, such that viral oncogene expression occurs at a high level throughout the epithelium (3,21).”
BackgroundDetection of human papillomavirus oncoprotein E7 in liquid-based cytology
Lidqvist, M., Nilsson, O., Holmgren, J. R., Hölters, S., Röijer, E., Dürst, M., & Fermér, C. (2011) · Journal of General Virology · doi:10.1099/vir.0.034884-0 · Cited by 5
“The genes are expressed at increasing levels during cancer development, often due to the integration of viral DNA into the host genome and loss of expression control, and are then abundantly expressed throughout the epithelia in high-grade cervical dysplasia and cervical cancer (Doorbar, 2006; von Knebel Doeberitz, 20…”
BackgroundLarsson, G. L., Kaliff, M., Bergengren, L., Karlsson, M. G., & Helenius, G. (2016) · Journal of Virological Methods · doi:10.1016/j.jviromet.2016.05.015 · Cited by 5
Kramer, B., Schultz, J. D., Hock, C., Sauter, A., Stuck, B. A., Hörmann, K., Birk, R., & Aderhold, C. (2017) · Oncology Letters · doi:10.3892/ol.2017.5844 · Cited by 5
“This genomic alteration leads to the over-expression of viral oncogenes E6 and E7, and subsequently results in a disruptive viral infection with an abrogation of cell cycle checkpoints (11).”
Carestiato, F. N., Filho, S. M. A., Moreira, M. Â. M., & Cavalcanti, S. M. B. (2018) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760180456 · Cited by 5
“(3) In the presence of HR-HPV, the E7 oncoprotein binds to pRB, maintaining a high level of free E2F, activating proliferation, independent of cyclinD/CdK4/6 induced phosphorylation.(3,4) Consequently, p16 accumulates in cells, in the absence of a feedback-mediated regulation, a reason for the association of p16ink4a…”
BackgroundInfluentialReinholz, M., Clanner-Engelshofen, B. M., Heppt, M. V., Hirai, Y., Ruzicka, T., Berking, C., & von Braunmühl, T. (2019) · Annals of Dermatology · doi:10.5021/ad.2019.31.4.434 · Cited by 5
Basto, D. L., Chaves, C. B. P., Felix, S. P., Filho, S. M. A., Vieira, V. C., Martins, L. F. L., de Carvalho, N. A., de Almeida, L. M., & Moreira, M. Â. M. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25624 · Cited by 5
Expression of p16 in cervical premalignant and malignant lesions- IHC study
Vedula, B., Rama Reddy, B., V, Rajani, M., Sree Ramulu Naidu, R., & Srikanth Reddy, K. (2020) · Indian Journal of Pathology and Oncology · doi:10.18231/j.ijpo.2020.080 · Cited by 5
Leucoplasia Bucal asociada al Virus de Papiloma Humano; infección bipolar en paciente joven
Costa, M. F. G., & Gilligan, G. (2020) · Revista de la Facultad de Ciencias Médicas de Córdoba · doi:10.31053/1853.0605.v77.n4.30733 · Cited by 5
Molecular Characterization of Human Papillomavirus Type 159 (HPV159)
Marković, I., Hošnjak, L., Seme, K., & Poljak, M. (2021) · Viruses · doi:10.3390/v13081668 · Cited by 5
“Unlike Alpha-PVs, Beta- and Gamma-PVs can persist on the skin for a longer time and they generally cause clinically insignificant viral infections [3,12,13].”
BackgroundLin, Z., Zhao, Y., Li, Q., Ci, X., Ye, X., Chen, G., Tu, Q., Feng, W., Jiang, P., Zhu, S., et al. (2022) · Carcinogenesis · doi:10.1093/carcin/bgac010 · Cited by 5
Sexually Transmitted Diseases: An Overview
Hughes, Y., & Sawleshwarkar, S. (2022) · Wiley eBooks · doi:10.1002/9781119826781.ch1 · Cited by 7
Biology of Papillomavirus Replication in Infected Epithelium
Doorbar, J., & Raj, K. (2007) · Future Virology · doi:10.2217/17460794.2.6.573 · Cited by 5
“In particular, the association of low-risk HPV types with genital and laryngeal warts, and the association of high-risk types with human cancers [6].”
BackgroundSelf-citationLeptomycin B induces apoptosis in cells containing the whole HPV 16 genome
Herrington, C. S. (2009) · International Journal of Oncology · doi:10.3892/ijo_00000377 · Cited by 5
Progress in the use of Immunotherapy to Treat Uterine Cervical Cancer
Lorenzo, B. H. P. D., Ramos, M. D. C., Michelin, M. A., & Murta, E. F. C. (2009) · Tumori Journal · doi:10.1177/030089160909500101 · Cited by 5
Absence of Canine Papillomavirus Sequences in Canine Mammary Tumours
Sardón, D., Blundell, R. J., Burrai, G. P., Alberti, A., Tore, G., Passino, E. S., & Antuofermo, E. (2014) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2014.10.001 · Cited by 5
“In human medicine, HPV 16 is the most prevalent type involved in the pathogenesis of human cervical carcinomas (Doorbar, 2006), while many other HPVs induce benign papillomas of skin and mucous membranes.”
Backgroundde Oliveira, C. M., Rangeiro, R., Osman, N., Baker, E., Neves, A., Mariano, A. A. N., Tivir, G., Thomas, J., Carns, J., Andrade, V., et al. (2025) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00655-1 · Cited by 4
“HPV is implicated as the cause of almost all cervical cancer cases, with HPV16 and 18 being responsible for 70% of cervical cancers [2–4].”
Simple and efficient co-synthesis of gold nanoparticles and nanoclusters for HPV-16 detection
Saleh, M. A., Hosseinkhani, S., Nikkhah, M., & Samani, Z. N. (2026) · Scientific Reports · doi:10.1038/s41598-026-35246-6 · Cited by 4
“A woman’s risk of acquiring cervical cancer is greatly increased by 15 of these high-risk variants, with strains 16, 18, 31, and 45 being particularly linked to the advancement of the cancer 5,6 .”
Sangrajrang, S., Laowahutanont, P., Wongsena, M., Muwonge, R., Imsamran, W., Ploysawang, P., & Basu, P. S. (2019) · Journal of Medical Screening · doi:10.1177/0969141319865922 · Cited by 4
“Human papillomavirus (HPV) infection is the ‘necessary’ cause of cervical cancer.(5) Of nearly 200 HPV genotypes, 14 are causally associated with cervical cancer, and are therefore termed high risk- (hr-) genotypes.”
BackgroundHigh-risk human papillomavirus distribution in different cytological classification women
Zheng, L., Zheng, L.-Y., Chen, C., Wang, Y.-T., Chen, S., Zhong, Q.-Q., Zhang, Y., & Li, X. (2023) · Microbes and Infection · doi:10.1016/j.micinf.2023.105214 · Cited by 5
López-Ansio, M., Ramos‐García, P., & González‐Moles, M. Á. (2025) · Cancers · doi:10.3390/cancers17020329 · Cited by 4
“As commented in the Section 1, it has also been shown in cervical and oropharyngeal cancer, closely associated with HPV infection, that these viruses inactivate pRb through E7 oncoprotein [11,12].”
Precursors of Vulvovaginal Squamous Cell Carcinoma
Oparka, R., & Herrington, C. S. (2012) · Springer eBooks · doi:10.1007/978-0-85729-757-0_6 · Cited by 4
“It also plays a role in viral DNA replication, through its binding to E1, and is important for genome maintenance through its ability to tether the HPV genome to host cell chromatin [ 56, 58, 60 ] .”
BackgroundInfluentialHuman Papilloma Viruses: Realities and Perspectives
Kalvatchev, Z., & Rösl, F. (2007) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2007.10817434 · Cited by 4
Xiao, Y., Wang, J., Ma, L., Ren, J., & Yang, M. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24381 · Cited by 4
Detection of HPV Infection and the Current Status of Vaccine Research: A Review
Su, L., Peng, H., & He, X. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5003048 · Cited by 4
“The five most prevalent popular HPV types in the world are HPV16, 18, 52, 31 and 58 [15].”
BackgroundHuman Papillomavirus: A Brief Overview
Xue, J., Vesper, B. J., & Radosevich, J. A. (2012) · Springer eBooks · doi:10.1007/978-94-007-5437-9_1 · Cited by 4
HPV16 infection regulates RASSF1A transcription mediated by p53
Lei, Y., Hu, C., Xu, H., & Tian, Y. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1529 · Cited by 4
HPV16 E6 oncoprotein increases cell adhesion in human keratinocytes
Epshtein, A., Jackman, A., Gonen, P., & Sherman, L. (2008) · Archives of Virology · doi:10.1007/s00705-008-0273-9 · Cited by 4
“The ability of HPV16 E6 to target apoptosis control proteins such as p53 and Bak for degradation has been strongly established by previous research [ 5 , 12, 27, 28, 34].”
BackgroundInfluentialGreen, V. A., Munshi, S. U., Marakalala, M. J., & Mourão, M. D. M. (2010) · IUBMB Life · doi:10.1002/iub.364 · Cited by 4
“7%) cervical cancers contain HPV DNA, usually types 16 and 18 (7).”
BackgroundVitković, L., Perisić, Z., Trajković, G., Mijović, M., Savić, S., Leštarević, S., & Đerković, B. (2015) · Praxis medica · doi:10.5937/pramed1504039v · Cited by 4
Human Papillomavirus: Epidemiology and Clinical Features of Related Cancer
Mayo, T. T., Imtiaz, R., Doan, H. Q., Sambrano, B. L., Gordon, R., Ramirez‐Fort, M. K., & Tyring, S. K. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0870-7_9 · Cited by 4
Khazaei, S., Izadi, B., Mirbahari, S. G., Madani, S. H., Khosravi, S. M., Aleagha, M. E., & Sajadimajd, S. (2016) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2016.17.12.5223 · Cited by 4
“The human papillomavirus DNA encodes 8 genes including E1, E2, E4, E5, E6, E7, L1 and L2 that are expressed in several phases of viral differentiation (Doorbar, 2006).”
Strzelczyk, J. K., Krakowczyk, Ł., Gołąbek, K., & Owczarek, A. J. (2018) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/79846 · Cited by 4
Tsakogiannis, D., Moschonas, G. D., Δάσκου, Μ., Stylianidou, Z., Kyriakopoulou, Z., Kottaridi, C., Dimitriou, T. G., Gartzonika, C., & Markoulatos, P. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000843 · Cited by 4
Kumar, A., Kumar, N., & Singh, B. (2021) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v11i3.4802 · Cited by 4
Li, Z., Xiao, Z., Feng, Y., Wang, Q., & Teng, M. (2021) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2021.102591 · Cited by 4
López-Ansio, M., Ramos‐García, P., & González‐Moles, M. Á. (2023) · Cancers · doi:10.3390/cancers15123132 · Cited by 5
“It has also been shown in cervical and oropharyngeal cancer, closely associated with HPV infection, that these viruses inactivate pRb through its E7 oncoprotein, this being the mechanism of oncogenic initiation [9,10], and similar findings have been documented for virus-induced hepatocarcinoma [11].”
BackgroundPeña, A. V., Illades‐Aguiar, B., Flores‐Alfaro, E., López‐Bayghen, E., Elba, R.-M., & Alarcón‐Romero, L. D. C. (2013) · Archives of Biological Sciences · doi:10.2298/abs1301081p · Cited by 4
“The oncoprotein E7 of HR-HPV promotes cellular proliferation upon joining in action with the protein Rb, increasing the kinetics of the cellular cycle and the overexpression of Ki-67 (Doorbar, 2006).”
BackgroundCastle, P. E. (2013) · Pathology Case Reviews · doi:10.1097/pcr.0b013e3182990eab · Cited by 4
“(eg, apoptosis) and a shift from viral production to overexpression of viral oncogenes.(15)”
BackgroundWang, Z., Zhou, W., Xiong, Z., Yu, T., Wu, L., Li, C., Yao, C., Wu, Y., & Hua, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.6405 · Cited by 4
“An opposite trend was observed in the level of p53 protein, which is consistent with the mechanism of p53 degradation by E6 (22).”
Bidinotto, L. T., V�o, C., Loaiza, E. A. A., Ribeiro, G., Lorenzi, A. T., Rosa, L. A. R., de Oliveira, C., Levi, J., Scapulatempo‐Neto, C., Longatto‐Filho, A., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8828 · Cited by 4
“Considering that HR-HPV infection is a fundamental step for cervical cancer development (9,10), there may be an inverse association between HR-HPV infection and RKIP expression, as was observed in the present study cohort.”
Metadata
- Authors
- Doorbar, J.
- Affiliations
- National Institute for Medical Research (GB)
- Corresponding author
- Doorbar, John
- ORCID
- Doorbar, John
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2006-04-11
- Volume
- 110
- Issue
- 5
- Pages
- 525-541
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2052489835
- Cited by
- 1,072
- References
- 179
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 34 · 2023: 41 · 2022: 51 · 2021: 43 · 2020: 52 · 2019: 45 · 2018: 60 · 2017: 55 · 2016: 58 · 2015: 64 · 2014: 73 · 2013: 98 · 2012: 83
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human papillomavirus, cervical cancer, HPV16, high-risk HPV, viral gene expression, cervical neoplasia, cervical transformation zone, E6 oncoprotein, E7 oncoprotein, retinoblastoma protein, p53 degradation, PDZ domain proteins, abortive infection, viral latency, immune clearance
- MeSH terms
- Uterine Cervical Neoplasms, Female, Humans, Precancerous Conditions, Virus Latency, Disease Progression, Papillomaviridae, Papillomavirus Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.